Table 1.

Baseline characteristics of reports on events of drug-induced hepatic autoimmune disorders.

Variables	Number (%)
Reporting region
African region	N/A
Region of the Americas	297 (21.20)
Southeast Asia region	N/A
European region	930 (66.38)
Eastern Mediterranean region	3 (0.21)
Western Pacific region	171 (12.21)
Reporting year
1968–1979	N/A
1980–1989	N/A
1990–1999	N/A
2000–2009	N/A
2010–2019	565 (40.33)
2020–2024	836 (59.67)
Reporter qualification
Health professional	613 (43.75)
Non-health professional	779 (55.60)
Unknown	9 (0.64)
Sex
Male	775 (55.32)
Female	556 (39.69)
Unknown	70 (5.00)
Age, yrs
1–17 yrs	6 (0.43)
18–44 yrs	98 (7.00)
44–64 yrs	409 (29.19)
65–74 yrs	275 (19.63)
≥75 yrs	197 (14.06)
Unknown	416 (29.69)
TTO, days
Mean days (SD)	22.90 (81.66)
Fatal outcomes
Recovered	738 (52.68)
Not recovered	158 (11.28)
Fatal	76 (5.42)
Death	N/A
Unknown	429 (30.62)
Single drug suspected	1401 (100.00)

SD = standard deviation, TTO = time to onset.